Metrovacesa revenue and financials

MVC · BME · EUR

€10.22Change from previous close: −0.58%Absolute change: −€0.06

Close · October 5, 2026

In the fiscal year ended December 2025, Metrovacesa reported revenue of €708.46M (+8.37% year over year). Net income was €56.86M, a net margin of 8.0%.

Annual revenue · 2025: €708.46M
  1. €519.21M2022
  2. €586.46M2023
  3. €653.76M2024
  4. €708.46M2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+8.37%
2025 vs 2024
Net income growth
+257.94%
2025 vs 2024
Net margin
8.0%
2024: 2.4%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue708654586519—
Cost of revenue529530459422—
Gross profit18012412897.1—
Selling, general and administrative23.825.623.424.2—
Operating income80.948.29.1-7.9—
EBIT94.454.56.5-7.1—
EBITDA95.654.59.7-0.5—
Interest expense21.930.023.011.2—
Pre-tax income72.524.5-16.5-18.3—
Income tax15.78.64.35.2—
Net income56.915.9-20.8-23.5—
Net income to common shareholders56.915.9-20.8-23.5—
Basic EPS—0.10-0.14-0.160.12
Diluted EPS—0.10-0.14-0.160.12
Average shares (basic)—152151151151
Average shares (diluted)—152151151151